Clinical Trials Directory

Trials / Terminated

TerminatedNCT01748162

Management of Recurrent Croup

Management of Recurrent Croup: Comparison Between Inhaled Fluticasone and Oral Prednisolone

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
6 Months – 15 Years
Healthy volunteers
Not accepted

Summary

Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential triggers (certain foods, environmental allergens, etc), and should episodes of croup recur they are treated with a short course of oral steroids. The purpose of this study is to compare two safe and clinically appropriate methods for treating recurrent croup, daily inhaled steroids versus observation with oral steroids on an as needed basis, to see if either is useful in preventing future episodes of croup.

Conditions

Interventions

TypeNameDescription
DRUGFluticasoneDaily inhaled steroids. Fluticasone 2 puffs inhaled orally twice daily for six months.
DRUGPrednisolone IF needed

Timeline

Start date
2012-09-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2012-12-12
Last updated
2017-11-13
Results posted
2017-11-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01748162. Inclusion in this directory is not an endorsement.